Heartmate XVE(R) destination therapy for end-stage heart failure in a patient with human immunodeficiency virus
2009; Oxford University Press; Volume: 9; Issue: 5 Linguagem: Inglês
10.1510/icvts.2009.212076
ISSN1569-9293
AutoresS. Mehmood, Danielle Blais, S. Martin, C.B. Sai-Sudhakar,
Tópico(s)Pneumocystis jirovecii pneumonia detection and treatment
ResumoCardiac dysfunction is a known predictor of survival in patients with acquired immunodeficiency syndrome. In this report, we describe a human immunodeficiency virus (HIV)-infected patient with worsening heart failure who was managed successfully for 16 months with placement of a left ventricular assist device.
Referência(s)